XML 13 R2.htm IDEA: XBRL DOCUMENT v3.7.0.1
CONDENSED CONSOLIDATED STATEMENT OF INCOME - USD ($)
$ in Millions
 3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Income Statement [Abstract]    
Sales $ 9,434 $ 9,312
Costs, Expenses and Other    
Materials and production 3,015 3,572
Marketing and administrative 2,411 2,318
Research and development 1,796 1,659
Restructuring costs 151 91
Other (income) expense, net 58 48
Total Costs, Expenses and Other 7,431 7,688
Income Before Taxes 2,003 1,624
Taxes on Income 447 494
Net Income 1,556 1,130
Less: Net Income Attributable to Noncontrolling Interests 5 5
Net Income Attributable to Merck & Co., Inc. $ 1,551 $ 1,125
Basic Earnings per Common Share Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) $ 0.56 $ 0.41
Earnings per Common Share Assuming Dilution Attributable to Merck & Co., Inc. Common Shareholders (in dollars per share) 0.56 0.40
Dividends Declared per Common Share (in dollars per share) $ 0.47 $ 0.46